News

Keytruda (pembrolizumab) in Patients with Multiple Myeloma: FDA Statement - Two Clinical Trials on Hold

Based on data from two recently halted clinical trials, the U.S.

FDA Safety Communication: Firmware Update to Address Cybersecurity Vulnerabilities Identified in Abbott's Implantable Cardiac Pacemakers

On August 23, 2017, the FDA approved a firmware update that is now available and is intended as a recall, specifically a corrective action,  to reduce the risk of patient harm due to potential exploitation of cybersecurity vulnerabilities for cert

Bella Pharmaceuticals, Inc. Issues Voluntary Nationwide Recall of All Sterile Drug Products Due to Lack of Sterility Assurance

August 18, 2017

Pages